JB
Jim Birchenough Wells Fargo Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
1
Sangamo Therapeutics
SGMO
$165M
| $0.5472 | $2 |
266%
upside
| Equal-Weight |
31 Dec ‘24
8 months ago |
|
2
CRISPR Therapeutics
CRSP
$4.99B
| $54.86 | $70 |
28%
upside
| Equal-Weight |
22 Feb ‘24
1 year ago |
|
3
MEI Pharma
MEIP
$139M
| $4.23 | $40 |
846%
upside
| Equal-Weight |
25 Mar ‘22
3 years ago |
|
4
Zymeworks
ZYME
$1.14B
| $15.05 | $48 |
219%
upside
| Overweight |
9 Feb ‘22
3 years ago |
|
|
ADAP
5
Adaptimmune Therapeutics
ADAP
$10.9M
| $0.0410 | $7 |
16,973%
upside
| Equal-Weight |
22 Sep ‘21
4 years ago |
|
6
Fate Therapeutics
FATE
$116M
| $1.01 | $130 |
12,771%
upside
| Overweight |
4 Mar ‘21
4 years ago |
|
7
Precigen
PGEN
$1.3B
| $4.36 | $14 |
221%
upside
| Overweight |
22 Feb ‘21
4 years ago |
|
8
Moderna
MRNA
$9.78B
| $25.14 | $145 |
477%
upside
| Equal-Weight |
1 Feb ‘21
4 years ago |
|
9
Gilead Sciences
GILD
$143B
| $115.05 | $63 |
45%
downside
| Equal-Weight |
29 Oct ‘20
4 years ago |
|
10
uniQure
QURE
$985M
| $17.95 | $56 |
212%
upside
| Equal-Weight |
25 Jun ‘20
5 years ago |
|
11
Regeneron Pharmaceuticals
REGN
$60.8B
| $573.38 | $734 |
28%
upside
| Overweight |
26 May ‘20
5 years ago |
|
12
Kezar Life Sciences
KZR
$29.8M
| $4.07 | $180 |
4,323%
upside
| Overweight |
13 Mar ‘20
5 years ago |
|